// App-Quantinova.ai

P1165 : BETALUTIN® IN PATIENTS WITH RELAPSED/ REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) NOT ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT

Researchers

Presenter

  • Timothy Illidge

Principal Investigators

  • Matthew Beasley

  • Jose Gomez Codina

  • Federica Cavallo

  • Veronique Pascal

  • Victoria Wills

Medical Centers

  • Haematology/Oncoloy,The Christie NHS Foundation Trust,Withington,Royaume-uni

  • Clinical Sciences,Nordic Nanovector ASA,Oslo,Noorwegen

  • Clinical Sciences,Nordic Nanovector ASA,Oslo,Noorwegen

  • Clinical Sciences,Nordic Nanovector ASA,Oslo,Noorwegen

  • Haematology/Oncoloy,The Christie NHS Foundation Trust,Withington,Royaume-uni

  • Haematology/Oncoloy,Bristol Haematology and Oncology Centre,Bristol,Vereinigtes Königreich

  • Bioanalytics,Nordic Nanovector ASA,Oslo ,Norvège

  • Bioanalytics,Nordic Nanovector ASA,Oslo ,Norvège

  • Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, A.O.U. Citt della Salute e della Scienza di Torino, Torino, Italy

  • Bioanalytics,Nordic Nanovector ASA,Oslo ,Norvège

  • Clinical Sciences,Nordic Nanovector ASA,Oslo,Noorwegen

  • Division of Hematol

  • Bioa

  • Clinical Sciences,Nordic Nanovector ASA,Oslo,Noorwegen

  • Haematology/Oncoloy,Bristol Haematology and Oncology Centre,Bristol,Regno Unito

  • Haematology/Oncoloy,The Christie NHS Foundation Trust,Withington,Royaume-uni

  • Haematology/Oncoloy,The Christie NHS Foundation Trust,Withington,Royaume-uni

  • Bioanalytics,Nordic Nanovector ASA,Oslo ,Norvège

  • Bioanalytics,Nordic Nanovector ASA,Oslo ,Norvège

  • Bioanalytics,Nordic Nanovector ASA,Oslo ,Норвегия

  • Haematology/Oncoloy,Bristol Haematology and Oncology Centre,Bristol,Regno Unito

  • Haematology/Oncoloy,Bristol Haematology and Oncology Centre,Bristol,Regno Unito

  • Hospital Universitari i Politècnic La Fe,Hospital Universitari i Politècnic La Fe, Valencia,Valencia,Spanien

  • Hospital Universitari i Politècnic La Fe,Hospital Universitari i Politècnic La Fe, Valencia,Valencia,Spanien

  • Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, A.O.U. Citt della Salute e della Scienza di Torino, Torino, Italy

  • Haematology/Oncoloy,The Christie NHS Foundation Trust,Withington,Royaume-uni

  • Haematology, Bristol Haematology and Oncology Centre, Bristol, Bristol, United Kingdom

  • Bioanalytics,Nordic Nanovector ASA,Oslo ,Norvège

  • Clinical Sciences,Nordic N

  • Hospital Universitari i Politècnic La Fe,Hospital Universitari i Politècni

  • Clinical Sciences,Nordic Nanovector ASA,Oslo,Noorwegen

  • Hospital Universitari i Politècnic La Fe,Hospital Universitari i Politècnic La Fe, Valencia,Valencia,Spanien

Locations

  • United Kingdom

  • United States

  • Venezuela

  • Italy

  • Norway

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Betalutin

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved